Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Akorn Inc (AKRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,196,099
  • Shares Outstanding, K 125,070
  • Annual Sales, $ 1,117 M
  • Annual Income, $ 184,240 K
  • 36-Month Beta 1.33
  • Price/Sales 4.47
  • Price/Cash Flow 11.29
  • Price/Book 4.72
  • Price/Earnings ttm 20.84
  • Earnings Per Share ttm 1.08
  • Most Recent Earnings 0.58 on 03/01/17
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    Indices S&P 400

    Medical - Generic Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
31.75 +5.67%
on 12/28/17
33.63 -0.24%
on 01/12/18
+1.35 (+4.19%)
since 12/12/17
3-Month
31.75 +5.67%
on 12/28/17
33.63 -0.24%
on 01/12/18
+0.39 (+1.18%)
since 10/12/17
52-Week
17.74 +89.12%
on 01/30/17
34.00 -1.32%
on 04/24/17
+11.68 (+53.41%)
since 01/12/17

Most Recent Stories

More News
Pomerantz LLP and Glancy Prongay & Murray LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Akorn, Inc. - AKRX

Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has approved the following announcement of a proposed...

AKRX : 33.55 (-0.03%)
54.1% Return Seen to Date on SmarTrend Akorn Inc Call (AKRX)

SmarTrend identified an Uptrend for Akorn Inc (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 11 months, Akorn Inc has returned 54.06% as of today's recent price of $33.40.

AKRX : 33.55 (-0.03%)
Watch for Akorn Inc to Potentially Pullback After Gaining 1.62% Yesterday

Akorn Inc (NASDAQ:AKRX) traded in a range yesterday that spanned from a low of $32.75 to a high of $33.35. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $32.77...

AKRX : 33.55 (-0.03%)
Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of Akorn, Inc.

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

AKRX : 33.55 (-0.03%)
Pomerantz LLP and Glancy Prongay & Murray LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Akorn, Inc. - AKRX

Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has approved the following announcement...

AKRX : 33.55 (-0.03%)
Akorn Inc Has Returned 49.1% Since SmarTrend Recommendation (AKRX)

SmarTrend identified an Uptrend for Akorn Inc (NASDAQ:AKRX) on February 15th, 2017 at $21.68. In approximately 10 months, Akorn Inc has returned 49.05% as of today's recent price of $32.31.

AKRX : 33.55 (-0.03%)
This Morning's Technical Outlook on Generic Drugs Stocks -- Versartis, Akorn, Rigel Pharma, and Medicines

In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has issued free tailored Stock Review on VSAR, AKRX, RIGL, and MDCO which is a click away at www.wallstequities.com/registration....

VSAR : 2.15 (+3.61%)
MDCO : 27.51 (+0.07%)
RIGL : 4.07 (-2.16%)
AKRX : 33.55 (-0.03%)
Analysis: Positioning to Benefit within Hertz Global, Cinedigm, Nektar Therapeutics, Akorn, Autodesk, and NextEra Energy Partners, LP -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Hertz Global Holdings, Inc...

CIDM : 1.37 (-0.72%)
ADSK : 115.91 (+2.34%)
NEP : 40.31 (+0.32%)
AKRX : 33.55 (-0.03%)
HTZ : 24.60 (+1.23%)
NKTR : 72.00 (+3.03%)
Stocks Already Have the Holiday Spirit

Stocks Already Have the Holiday Spirit

MCFT : 21.84 (+1.30%)
YNDX : 34.60 (+0.06%)
VSM : 38.97 (+0.05%)
ZUMZ : 22.90 (+2.23%)
ATEN : 7.58 (+0.66%)
PDCE : 55.65 (+0.31%)
MOH : 85.82 (+1.67%)
LBTYA : 36.87 (+0.77%)
IAC : 134.70 (+0.76%)
EC : 16.87 (-1.92%)
AKRX : 33.55 (-0.03%)
MRVL : 23.84 (+2.98%)
Portfolios Active as Market Pulls Back

Portfolios Active as Market Pulls Back

EFII : 30.26 (+0.90%)
ICHR : 24.74 (-1.75%)
WIX : 61.90 (+1.64%)
LBTYA : 36.87 (+0.77%)
LYV : 44.43 (+1.53%)
LLNW : 4.23 (-3.86%)
AKRX : 33.55 (-0.03%)
SIG : 56.94 (+3.11%)
MELI : 342.47 (+0.13%)
UNVR : 31.65 (+0.22%)
LEN : 69.26 (-0.45%)
ZAYO : 36.46 (-0.16%)
EVBG : 32.24 (+1.51%)
IBP : 73.00 (-0.34%)
HPE : 15.81 (+2.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals,...

See More

Key Turning Points

2nd Resistance Point 33.99
1st Resistance Point 33.77
Last Price 33.55
1st Support Level 33.19
2nd Support Level 32.83

See More

52-Week High 34.00
Last Price 33.55
Fibonacci 61.8% 27.79
Fibonacci 50% 25.87
Fibonacci 38.2% 23.95
52-Week Low 17.74

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.